Background: Activated leucocyte cell adhesion molecule (ALCAM, CD166) is a cell surface member of the immunoglobulin superfamily. ALCAM expression has prognostic relevance in prostate and colon cancer.
Objective: To evaluate ALCAM protein expression in breast cancer by immunohistochemistry and to correlate expression levels with clinicopathological data.
Methods: 162 primary breast carcinomas with a mean clinical follow up time of 53 months were immunostained using a monoclonal ALCAM antibody. The staining was evaluated as an immunoreactive score (IRS) and grouped into low v high for both membranous and cytoplasmic staining.
Results: Intraductal and invasive carcinomas showed a higher ALCAM expression (median IRS 4 and 6 respectively) than normal breast tissue (IRS 2). In univariate survival analyses a significant association of high cytoplasmic ALCAM expression with shortened patient disease-free survival (mean (SD) five year non-progression rate, 69.4 (4.6)% v 49.4 (11.1)%, p = 0.0142) was found. In multivariate analyses of disease-free survival times, high cytoplasmic ALCAM expression (relative risk (RR) = 2.086, p = 0.026) and nodal status (RR = 2.246, p = 0.035) were significantly associated with earlier disease progression, whereas tumour grading (RR = 1.6, p = 0.052) was of borderline significance.
Conclusions: The data suggest that strong cytoplasmic ALCAM expression in primary breast cancer, as detected by immunohistochemistry, might be a new marker for a more aggressive breast cancer biology.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1860378 | PMC |
| http://dx.doi.org/10.1136/jcp.2005.028209 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Ligands of CD6: roles in the pathogenesis and treatment of cancer.
Front Immunol
January 2025
Division of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, United States.
Cluster of Differentiation 6 (CD6), an established marker of T cells, has multiple and complex functions in regulation of T cell activation and proliferation, and in adhesion of T cells to antigen-presenting cells and epithelial cells in various organs and tissues. Early studies on CD6 demonstrated its role in mediating cell-cell interactions through its first ligand to be identified, CD166/ALCAM. The observation of CD6-dependent functions of T cells that could not be explained by interactions with CD166/ALCAM led to discovery of a second ligand, CD318/CDCP1.
View Article and Find Full Text PDFUrinary Immune Complexes Reflect Renal Pathology in Lupus Nephritis.
Diagnostics (Basel)
December 2024
Department of Biomedical Engineering, University of Houston, Houston, TX 77204, USA.
Background/objectives: Lupus nephritis (LN) is a serious complication of systemic lupus erythematosus (SLE), involving immune complex deposition in the kidneys. While renal biopsy is the diagnostic gold standard, its invasiveness limits frequent use, driving the need for non-invasive urinary biomarkers to monitor disease progression and response to treatment. This study aimed to identify and validate urinary biomarkers for LN.
View Article and Find Full Text PDFALCAM is an entry factor for severe community acquired Pneumonia-associated Human adenovirus species B.
Nat Commun
December 2024
Department of Pulmonary and Critical Care Medicine, Ruijin Hospital, Institutes of Respiratory Diseases, School of Medicine, Shanghai Jiao Tong University and Shanghai Key Laboratory of Emergency Prevention, Diagnosis and Treatment of Respiratory Infectious Diseases, Shanghai, China.
Human adenovirus (HAdV) is a widely spread respiratory pathogen that can cause infections in multiple tissues and organs. Previous studies have established an association between HAdV species B (HAdV-B) infection and severe community-acquired pneumonia (SCAP). However, the connection between SCAP-associated HAdV-B infection and host factor expression profile in patients has not been systematically investigated.
View Article and Find Full Text PDFInference and analysis of cell-cell communication of non-myeloid circulating cells in late sepsis based on single-cell RNA-seq.
IET Syst Biol
December 2024
Institute of Critical Care Medicine, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, China.
Article Synopsis
- * Researchers used single-cell RNA sequencing to analyze communication between immune cells in late-stage sepsis, discovering increased cellular interactions in septic patients compared to healthy ones, especially in specific immune cells known as dendritic cells.
- * Key pathways were found to be more activated in sepsis, indicating a potential suppression of T cells, which gives new insights into immune dysfunction and suggests possible targets for future treatments.
Rhaponticin suppresses the stemness phenotype of gastric cancer stem-like cells CD133+/CD166 + by inhibiting programmed death-ligand 1.
BMC Gastroenterol
November 2024
Department of Gastroenterology, Shaanxi Provincial People's Hospital, No. 256 Friendship West Road, Beilin District, Xi'an, Shaanxi, 710068, China.
Article Synopsis
- Gastric cancer stem cells (GCSCs) are crucial for tumor growth and recurrence, making them important targets for treatments; Rhaponticin (RA) is a new anticancer drug that may affect GCSCs' properties.
- In experiments, isolated GCSCs showed stem-like traits and were sensitive to RA, which decreased their viability and stemness markers without harming normal cells; RA showed a pronounced effect in two specific gastric cancer cell lines.
- Additionally, RA appears to target the PD-L1 gene, and studies in a mouse model demonstrated that RA significantly reduced tumor size compared to untreated GCSCs, suggesting potential therapeutic benefits for gastric cancer patients.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!